Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
letter
. 1989 Sep;82(9):571–573. doi: 10.1177/014107688908200933

Malignant mesothelioma.

E Heyderman, P D Ridley
PMCID: PMC1292317  PMID: 2795586

Full text

PDF
571

Images in this article

572Figure 1.
on p.572

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Battifora H., Kopinski M. I. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer. 1985 Apr 15;55(8):1679–1685. doi: 10.1002/1097-0142(19850415)55:8<1679::aid-cncr2820550812>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  2. Blobel G. A., Moll R., Franke W. W., Kayser K. W., Gould V. E. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol. 1985 Nov;121(2):235–247. [PMC free article] [PubMed] [Google Scholar]
  3. Burchell J., Durbin H., Taylor-Papadimitriou J. Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol. 1983 Jul;131(1):508–513. [PubMed] [Google Scholar]
  4. Churg A. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol. 1985 May;9(5):360–365. doi: 10.1097/00000478-198505000-00006. [DOI] [PubMed] [Google Scholar]
  5. Corson J. M., Pinkus G. S. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol. 1982 Jul;108(1):80–88. [PMC free article] [PubMed] [Google Scholar]
  6. Dewar A., Valente M., Ring N. P., Corrin B. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison. J Pathol. 1987 Aug;152(4):309–316. doi: 10.1002/path.1711520409. [DOI] [PubMed] [Google Scholar]
  7. Gatter K. C., Dunnill M. S., Van Muijen G. N., Mason D. Y. Human lung tumours may coexpress different classes of intermediate filaments. J Clin Pathol. 1986 Sep;39(9):950–954. doi: 10.1136/jcp.39.9.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Heyderman E., Strudley I., Powell G., Richardson T. C., Cordell J. L., Mason D. Y. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2. Br J Cancer. 1985 Sep;52(3):355–361. doi: 10.1038/bjc.1985.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holden J., Churg A. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol. 1984 Apr;8(4):277–279. doi: 10.1097/00000478-198404000-00004. [DOI] [PubMed] [Google Scholar]
  10. Kittas C., Aroni K., Kotsis L., Papadimitriou C. S. Distribution of lysozyme, alpha 1-Antichymotrypsin and alpha 1-Antitrypsin in adenocarcinomas of the stomach and large intestine. An immunohistochemical study. Virchows Arch A Pathol Anat Histopathol. 1982;398(2):139–147. doi: 10.1007/BF00618865. [DOI] [PubMed] [Google Scholar]
  11. Kwee W. S., Veldhuizen R. W., Golding R. P., Mullink H., Stam J., Donner R., Boon M. E. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining. Virchows Arch A Pathol Anat Histol. 1982;397(3):287–299. doi: 10.1007/BF00496570. [DOI] [PubMed] [Google Scholar]
  12. Lee I., Radosevich J. A., Chejfec G., Ma Y. X., Warren W. H., Rosen S. T., Gould V. E. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12. Am J Pathol. 1986 Jun;123(3):497–507. [PMC free article] [PubMed] [Google Scholar]
  13. Makin C. A., Bobrow L. G., Bodmer W. F. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol. 1984 Sep;37(9):975–983. doi: 10.1136/jcp.37.9.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Norton A. J., Thomas J. A., Isaacson P. G. Cytokeratin-specific monoclonal antibodies are reactive with tumours of smooth muscle derivation. An immunocytochemical and biochemical study using antibodies to intermediate filament cytoskeletal proteins. Histopathology. 1987 May;11(5):487–499. doi: 10.1111/j.1365-2559.1987.tb02657.x. [DOI] [PubMed] [Google Scholar]
  15. Said J. W., Nash G., Tepper G., Banks-Schlegel S. Keratin proteins and carcinoembryonic antigen in lung carcinoma: an immunoperoxidase study of fifty-four cases, with ultrastructural correlations. Hum Pathol. 1983 Jan;14(1):70–76. doi: 10.1016/s0046-8177(83)80048-3. [DOI] [PubMed] [Google Scholar]
  16. Twining S. S., Brecher A. S. Isolation and identification of alpha1-antitrypsin as a component of normal and malignant human breast and other tissues. Proc Soc Exp Biol Med. 1975 Oct;150(1):98–103. doi: 10.3181/00379727-150-38981. [DOI] [PubMed] [Google Scholar]
  17. Wang N. S., Huang S. N., Gold P. Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer. 1979 Sep;44(3):937–943. doi: 10.1002/1097-0142(197909)44:3<937::aid-cncr2820440322>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  18. Whitaker D., Shilkin K. B. Diagnosis of pleural malignant mesothelioma in life--a practical approach. J Pathol. 1984 Jul;143(3):147–175. doi: 10.1002/path.1711430303. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES